Teleflex Incorporated (TFX) Shares Sold by Castleark Management LLC
Castleark Management LLC trimmed its position in shares of Teleflex Incorporated (NYSE:TFX) by 7.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,780 shares of the medical technology company’s stock after selling 1,890 shares during the quarter. Castleark Management LLC owned approximately 0.05% of Teleflex worth $4,733,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently modified their holdings of TFX. Janus Henderson Group PLC grew its stake in Teleflex by 50,429.2% during the second quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after buying an additional 1,812,426 shares during the last quarter. Marshall Wace North America L.P. grew its stake in Teleflex by 137.4% during the second quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock worth $107,840,000 after buying an additional 300,069 shares during the last quarter. Principal Financial Group Inc. grew its stake in Teleflex by 93.5% during the second quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock worth $126,816,000 after buying an additional 294,935 shares during the last quarter. FMR LLC grew its stake in Teleflex by 46.5% during the first quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock worth $157,263,000 after buying an additional 257,649 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in Teleflex by 22.8% during the second quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock worth $174,327,000 after buying an additional 155,863 shares during the last quarter. 89.75% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/10/14/teleflex-incorporated-tfx-shares-sold-by-castleark-management-llc.html.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $211.75, for a total transaction of $42,350.00. Following the sale, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,710,940. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 600 shares of company stock worth $132,408 over the last ninety days. 2.39% of the stock is currently owned by insiders.
Teleflex Incorporated (TFX) traded down 0.55% during mid-day trading on Friday, hitting $238.71. 242,084 shares of the stock traded hands. The stock has a market capitalization of $10.75 billion, a PE ratio of 45.65 and a beta of 1.07. The company has a 50 day moving average price of $232.90 and a 200-day moving average price of $211.02. Teleflex Incorporated has a one year low of $136.53 and a one year high of $248.68.
Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.91 by $0.13. The company had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The firm’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.89 EPS. Equities analysts anticipate that Teleflex Incorporated will post $8.29 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Tuesday, August 15th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.57%. The ex-dividend date of this dividend was Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is presently 26.00%.
TFX has been the topic of several research analyst reports. Morgan Stanley raised shares of Teleflex from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $220.00 to $274.00 in a research note on Wednesday, September 6th. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $261.00 price target on the stock in a research note on Tuesday, September 12th. Jefferies Group LLC increased their price target on shares of Teleflex from $253.00 to $270.00 and gave the company a “buy” rating in a research note on Friday, September 8th. Barclays PLC reissued a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Finally, Needham & Company LLC increased their price target on shares of Teleflex from $228.00 to $237.00 and gave the company a “buy” rating in a research note on Tuesday, September 5th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $260.75.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.